Article
Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects.
Journal of biomedicine & biotechnology - 1 Jan 2012
Al-Hamodi Zaid, Saif-Ali Riyadh, Ismail Ikram S, Ahmed Khaled A, Muniandy Sekaran
Abstract excerpt
Elevated activity of plasminogen activator inhibitor-1 (PAI-1) and decreased tissue plasminogen activator (tPA) activity are considered to be important risk factors for type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS). The aim of this study was to investigate the association of the PAI-1 4G/5G and tPA Alu-repeat I/D polymorphisms with T2DM in Malaysian subjects. Serum insulin, coronary risk panel,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
